IJMS | Free Full-Text | How to Predict Metastasis in Luminal Breast Cancer? Current Solutions and Future Prospects
Frontiers | Prognostic Relevance of Progesterone Receptor Levels in Early Luminal-Like HER2 Negative Breast Cancer Subtypes: A Retrospective Analysis
Luminal B Breast Cancer: Symptoms, Diagnosis, and Treatment
Breast cancer survival in Mexico between 2007 and 2016 in women without social security: a retrospective cohort study - The Lancet Regional Health – Americas
Frontiers | High Parity Predicts Poor Outcomes in Patients With Luminal B-Like (HER2 Negative) Early Breast Cancer: A Prospective Finnish Single-Center Study
Triple negative breast cancer therapies nanomedicine - Inside Tx
Prognosis of Tumor Microenvironment in Luminal B-Type Breast Cancer
Breast Cancer Subtypes And Prognosis | BCTT
Molecular profiles of genomically High Risk ER+ HER2- breast cancer tumors classified as functionally Basal or Luminal B by the BluePrint - Agendia
Revisiting the impact of age and molecular subtype on overall survival after radiotherapy in breast cancer patients | Scientific Reports
Breast Cancer Types | Breast Cancer Trials
:max_bytes(150000):strip_icc()/GettyImages-1164234982-17a305f7dbaf4f4fb29ca25003cde65b.jpg "Luminal A Breast Cancer: Causes, Diagnosis, and Treatment")
Luminal A Breast Cancer: Causes, Diagnosis, and Treatment
Luminal B Breast Cancer | Breast Cancer Trials
Long-term outcomes of non-metastatic breast cancer patients by molecular subtypes | BMC Women's Health | Full Text
Cancers | Free Full-Text | Co-Targeting Luminal B Breast Cancer with S-Adenosylmethionine and Immune Checkpoint Inhibitor Reduces Primary Tumor Growth and Progression, and Metastasis to Lungs and Bone
Five-year survival in luminal breast cancer patients: relation with intratumoral activity of proteasomes - Sereda - Translational Breast Cancer Research
:max_bytes(150000):strip_icc()/GettyImages-1389278061-ca025a5867e04ce18d7fc1b2ecba8ce2.jpg "Luminal B Breast Cancer: Symptoms, Diagnosis, and More")
Luminal B Breast Cancer: Symptoms, Diagnosis, and More
The regrouping of Luminal B (HER2 negative), a better discriminator of outcome and recurrence score - Yang - 2023 - Cancer Medicine - Wiley Online Library
The CINSARC signature predicts the clinical outcome in patients with Luminal B breast cancer | npj Breast Cancer
Impact of molecular subtypes on metastatic breast cancer patients: a SEER population-based study | Scientific Reports
Integrative analysis identifies two molecular and clinical subsets in Luminal B breast cancer - ScienceDirect
Five-year survival in luminal breast cancer patients: relation with intratumoral activity of proteasomes - Sereda - Translational Breast Cancer Research
Breast Cancer Subtypes And Prognosis | BCTT
Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients - The Lancet Oncology
Integrative analysis identifies two molecular and clinical subsets in Luminal B breast cancer - ScienceDirect
Long-term outcomes of non-metastatic breast cancer patients by molecular subtypes | BMC Women's Health | Full Text
Overall survival depends on tumor subtype and systemic treatment. a... | Download Scientific Diagram
